173 related articles for article (PubMed ID: 16757558)
21. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
[TBL] [Abstract][Full Text] [Related]
22. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.
Usuda S; Okamoto H; Iwanari H; Baba K; Tsuda F; Miyakawa Y; Mayumi M
J Virol Methods; 1999 Jun; 80(1):97-112. PubMed ID: 10403681
[TBL] [Abstract][Full Text] [Related]
23. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
[TBL] [Abstract][Full Text] [Related]
24. A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.
Margeridon S; Lachaux A; Trepo C; Zoulim F; Kay A
J Gen Virol; 2005 Jun; 86(Pt 6):1687-1693. PubMed ID: 15914846
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product.
Usuda S; Okamoto H; Tanaka T; Kidd-Ljunggren K; Holland PV; Miyakawa Y; Mayumi M
J Virol Methods; 2000 Jun; 87(1-2):81-9. PubMed ID: 10856755
[TBL] [Abstract][Full Text] [Related]
27. Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants.
Wu CR; Kim HJ; Sun CP; Chung CY; Lin YY; Tao MH; Kim JH; Chen DS; Chen PJ
Hepatology; 2022 Jul; 76(1):207-219. PubMed ID: 34957587
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response.
Waters JA; Brown SE; Steward MW; Howard CR; Thomas HC
Virus Res; 1992 Jan; 22(1):1-12. PubMed ID: 1371369
[TBL] [Abstract][Full Text] [Related]
29. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
30. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
Itoh Y; Takai E; Ohnuma H; Kitajima K; Tsuda F; Machida A; Mishiro S; Nakamura T; Miyakawa Y; Mayumi M
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9174-8. PubMed ID: 3466181
[TBL] [Abstract][Full Text] [Related]
31. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
32. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
33. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes.
Sominskaya I; Pushko P; Dreilina D; Kozlovskaya T; Pumpen P
Med Microbiol Immunol; 1992; 181(4):215-26. PubMed ID: 1279369
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.
Petit MA; Dubanchet S; Capel F
Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766
[TBL] [Abstract][Full Text] [Related]
35. In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.
Kim SH; Kim SH; Oh HK; Ryu CJ; Park SY; Hong HJ
Exp Mol Med; 2008 Feb; 40(1):145-9. PubMed ID: 18305407
[TBL] [Abstract][Full Text] [Related]
36. Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant.
Sällberg M; Rudén U; Wahren B; Noah M; Magnius LO
Mol Immunol; 1991 Jul; 28(7):719-26. PubMed ID: 1713295
[TBL] [Abstract][Full Text] [Related]
37. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
[TBL] [Abstract][Full Text] [Related]
38. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
39. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
Wi J; Jeong MS; Hong HJ
J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
[TBL] [Abstract][Full Text] [Related]
40. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.
Zhang P; Zhong L; Struble EB; Watanabe H; Kachko A; Mihalik K; Virata ML; Alter HJ; Feinstone S; Major M
Proc Natl Acad Sci U S A; 2009 May; 106(18):7537-41. PubMed ID: 19380744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
